Long-term aspirin use for cancer primary prevention: A protocol for updated systematic review and subgroup meta-analysis of randomized clinical trials

BACKGROUND: Long-term use of aspirin for primary prevention of cancer remains inconclusive, and variation in the effects of aspirin use on cancer outcomes by cancer site, aspirin dose, follow-up duration, or different populations has never been systematically evaluated. METHODS: Seven electronic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qibiao, Chen, Hongwei, Yao, Xiaojun, Li, Ting, Xu, Cong, Wang, Jue, Sui, Xinbing, Leung, Elaine Lai-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775419/
https://www.ncbi.nlm.nih.gov/pubmed/31574890
http://dx.doi.org/10.1097/MD.0000000000017382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775419/
https://www.ncbi.nlm.nih.gov/pubmed/31574890
http://dx.doi.org/10.1097/MD.0000000000017382

Ejemplares similares